Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease

BACKGROUND. Noninvasive detection of Alzheimer’s disease (AD) with high specificity and sensitivity can greatly facilitate identification of at-risk populations for earlier, more effective intervention. AD patients exhibit a myriad of retinal pathologies, including hallmark amyloid β-protein (Aβ) de...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JCI Insight
Prif Awduron: Koronyo, Yosef, Biggs, David, Barron, Ernesto, Boyer, David S., Pearlman, Joel A., Au, William J., Kile, Shawn J., Blanco, Austin, Fuchs, Dieu-Trang, Ashfaq, Adeel, Frautschy, Sally, Cole, Gregory M., Miller, Carol A., Hinton, David R., Verdooner, Steven R., Black, Keith L., Koronyo-Hamaoui, Maya
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Clinical Investigation 2017
Pynciau:
Clinical Medicine
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5621887/
https://ncbi.nlm.nih.gov/pubmed/28814675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.93621
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg